Analyst Ratings for Sucampo Pharmaceuticals Inc. Cl A (SCMP)

Updated: 2017-07-28

An average rating of Buy has been given to Sucampo Pharmaceuticals Inc. Cl A (NASDAQ:SCMP) by analysts covering the stock. SCMP had previously received a consensus rating of Buy a month ago.

4 analysts declared SCMP a buy, 0 issued an overweight rating, 1 gave a hold rating, 0 issued an underweight rating, and 0 issued a sell rating. Compared to three months ago, there has been an increase of 0 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Several price targets were given for SCMP by the analysts covering the stock. The most optimistic price target was 29.5, implying potential capital gains of 171.89 percent. The most pessimistic price target was 11, which equates to a potential downside of 1.38 percent. Note that investment analysts can be biased in their reporting on companies's ratings and price targets.

In the last 30 days, analysts have changed their quarterly earnings estimates upwards by an average of 0 percent. The average change in earnings estimates over the last 90 days is -8.07 percent. Over the past 30 days, FY earnings estimates have also changed upwards by 0 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes -12.21 percent.

People are often interested in whether analysts were united in the direction of their revisions. Over the past month, 0 analysts increased their quarterly estimates, which can be compared to the 0 analysts that decreased their estimates. Also over the last month, 0 analysts increased their estimates for the FY earnings, compared to 0 analysts that revised their FY estimates downwards.

The growth rate of SCMP's earnings is estimated by analysts to be 66.42 percent. Another measure frequently examined by investors is the PEG ratio. Smaller PEG ratios are desirable, because people typically see that as an indicator of higher growth relative to stock price. People often look for the PEG ratio to be under 1, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of SCMP is 0.27.

SCMP has traded between a high of 17.55 and a low of 9.30 over the past year. The current market price is above the trailing year's low by 16.67 percent, and 38.18 percent lower than its 52-week high. SCMP has a price/earnings ratio of 17.79. Investors typically compare the P/E ratio to a company's peers in the industry. The SCMP value stock report compares SCMP to some of its peers using value stock charts. The stock has a market capitalization of $0.50182 billion. SCMP's next earnings release will be on 0000-00-00, which is days away.